RNVU1-29

Across TCGA pan-cancer cohorts, RNVU1-29 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RNVU1-29 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RNVU1-29 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNVU1-29 expression acts as an unfavorable survival marker, although some lineages such as PAAD and UCS show a favorable association.

PAAD, UCS, and KICH are the cancer types where RNVU1-29 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.459	0.203	.001	47	view →
UCS	OS	Tertile	III,IV	0.809	0.456	.018	36	view →
KICH	DFS	Tertile	All	0.520	0.910	.004	33	view →
MESO	OS	Quartile	II,III,IV	0.234	0.642	.010	30	view →
ESCA	DFS	Tertile	II,III,IV	0.383	0.612	.005	27	view →
UVM	OS	Tertile	All	0.320	0.789	.010	27	view →
READ	DFS	Tertile	All	0.738	0.854	.016	27	view →
OV	DFS	Median	IV	0.363	0.537	.013	20	view →
ACC	OS	Median	IV	0.915	0.295	.003	18	view →
THYM	OS	Tertile	IV	0.294	1.000	.025	18	view →
STAD	DFS	Median	IV	0.702	0.323	.024	15	view →
COAD	OS	Tertile	All	0.937	0.766	.024	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RNVU1-29–PAAD (DFS)

Open the PAAD breakdown →